Generalized flare of pustular psoriasis induced by PEGylated interferon-α2b therapy for chronic hepatitis C

Australas J Dermatol. 2012 Nov;53(4):e69-72. doi: 10.1111/j.1440-0960.2011.00767.x. Epub 2011 May 31.

Abstract

New onset or exacerbation of psoriasis vulgaris has been reported in a small number of patients after interferon (IFN)-α therapy. Herein, we report a case of generalized flare of pustular psoriasis induced by PEGylated IFN-α2b (PEG-IFN-α2b) in a 59-year-old woman with a 15-year history of pustular psoriasis and chronic hepatitis C. Interferon-α therapy was discontinued and the rash resolved after treatment with cyclosporin and systemic methylprednisolone. The potential side effect of PEG-IFN-α2b in inducing or exacerbating psoriasis should be kept in mind when treating patients with a history of psoriasis or pustular psoriasis.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / adverse effects*
  • Disease Progression
  • Drug Eruptions / etiology*
  • Female
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects*
  • Middle Aged
  • Polyethylene Glycols / adverse effects*
  • Psoriasis / chemically induced*
  • Recombinant Proteins / adverse effects

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2b